Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer

• Published in: Frontiers in oncology 2020-10, Vol.10, p.568911
• Main Authors: Xu, Ting, Zhang, Yinjie, Zhang, Jing, Qi, Changsong, Liu, Dan, Wang, Zhenghang, Li, Yanyan, Ji, Congcong, Li, Jian, Lin, Xuan, Hou, Ting, Liu, Hao, Zhang, Lu, Han-Zhang, Han, Shen, Lin, Wang, Xicheng
• Format: Article
• Language: English
• Subjects: early onset colorectal cancer; genomic alternation; next generation sequencing; Oncology; prognosis; susceptibility gene
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2020.568911

Early onset colorectal cancer (EO CRC) is a heterogeneous colorectal cancer subtype with obvious hereditary tendencies and increasing incidence. We sought to determine the susceptibility genes and molecular characteristics of EO CRC. 330 EO metastatic CRC (mCRC) (≤55 years) and 110 average-onset (AO) mCRC patients (>55 years) were enrolled. Capture-based targeted sequencing was performed on tumor tissue and paired white blood cells using a sequencing panel of 520 genes. The association between molecular alterations and overall survival (OS) was analyzed. Of the 330 EO mCRC patients, 31 carried pathogenic or likely pathogenic germline mutations, with 16 of them diagnosed with lynch syndrome. Fifteen patients had germline mutations in non-mismatch repair genes, including four in MUTHY, three in RAD50, one in TP53, and eight in other genes. Twenty-nine genes were recurrently mutated in EO mCRC, including TP53, APC, KRAS, SMAD4, and BRCA2. The majority of genomic alterations were comparable between EO and AO mCRC. EO mCRC patients were more likely to have a high tumor mutation burden (p < 0.05). RNF43, RBM10, TSC, and BRAF V600E mutations were more commonly observed in EO mCRC, while APC, ASXL1, DNMT3B, and MET genes were more commonly altered in AO patients. At the pathway level, the WNT pathway was the only differentially mutated pathway between EO and AO mCRC (p < 0.0001). The wild-type WNT pathway (p = 0.0017) and mutated TGF- pathway (p = 0.023) were associated with unfavorable OS in EO mCRC. Approximately one in 10 EO mCRC was associated with hereditary tumors. The spectrum of somatic alterations was largely comparable between EO and AO mCRC with several notable differences.